Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective, randomized, multi-center, single-blind study to demonstrate the safety and effectiveness of the CVI Paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon versus bare PTA balloon for the treatment of patients with de novo occluded/stenotic or reoccluded/restenotic lesions of the superficial femoral (SFA) and popliteal arteries.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Paclitaxel-coated balloon | Experimental | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. |
|
| Bare balloon | Placebo Comparator | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter | Device |
| ||
| Bare Percutaneous Transluminal Angioplasty Balloon Catheter |
| Measure | Description | Time Frame |
|---|---|---|
| Patency at 12-months | The primary efficacy endpoint was patency at 12 months post-procedure defined as the absence of target lesion restenosis determined by duplex ultrasound peak systolic velocity ratio (PSVR) ≤2.5 and freedom from clinically-driven target lesion revascularization (CD-TLR). | 12 months |
| Percentage of Patients With Freedom From Device and Procedure Related Target Limb Major Amputation or Death Through 30-days Post-procedure and Clinically-driven Target Lesion Revascularization at 12-month | The primary safety endpoint was freedom from device and procedure-related death through 30 days post-procedure and freedom from target limb major amputation and clinically-driven target lesion revascularization (CD-TLR) through 12 months post-procedure. | 30-Days and 12-Months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Henrik Schroeder, M.D. | Center for Diagnostic Radiology & Minimally Invasive Therapy, The Jewish Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Diagnostic Radiology and Minimally Invasive Therapy | Berlin | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28424223 | Result | Schroeder H, Werner M, Meyer DR, Reimer P, Kruger K, Jaff MR, Brodmann M; ILLUMENATE EU RCT Investigators. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Circulation. 2017 Jun 6;135(23):2227-2236. doi: 10.1161/CIRCULATIONAHA.116.026493. Epub 2017 Apr 19. | |
| 30522663 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Paclitaxel-coated Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter |
| FG001 | Bare Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. Bare Percutaneous Transluminal Angioplasty Balloon Catheter |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
The Baseline Participants are based on the Intent-to-Treat (ITT) analysis set. The safety data for the adverse events section will be based on the Safety Set which has 219 participants in the Paclitaxel-coated arm and 68 in the Bare balloon arm.
| ID | Title | Description |
|---|---|---|
| BG000 | Paclitaxel-coated Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter |
| BG001 | Bare Balloon |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Patency at 12-months | The primary efficacy endpoint was patency at 12 months post-procedure defined as the absence of target lesion restenosis determined by duplex ultrasound peak systolic velocity ratio (PSVR) ≤2.5 and freedom from clinically-driven target lesion revascularization (CD-TLR). | The analysis for the primary patency was based on the lesion success and not participant success. In the Paclitaxel-coated balloon arm, 222 subjects represents 254 lesions. Of those 254 lesions, only 224 lesions were evaluable. In the Bare balloon arm, 72 subjects represents 79 lesions. Of those 79 lesions, only 66 lesions were evaluable. | Posted | Number | 95% Confidence Interval | percentage of lesions | 12 months | lesions | lesions |
|
The adverse events presented were collected through 12 Months. The data presented is based off the Safety Set (analysis set). The Safety Set excludes 7 participants who were not treated with a study device.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Paclitaxel-coated Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| ANAEMIA | Blood and lymphatic system disorders | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| ANAEMIA | Blood and lymphatic system disorders | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Nicolas Aguirre | Spectranetics | +1-312-297-6655 | nicolas.aguirre@philips.com |
Not provided
| ID | Term |
|---|---|
| D058729 | Peripheral Arterial Disease |
| D007383 | Intermittent Claudication |
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
|
| Result |
| Brodmann M, Werner M, Meyer DR, Reimer P, Kruger K, Granada JF, Jaff MR, Schroeder H; ILLUMENATE EU RCT Investigators. Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2357-2364. doi: 10.1016/j.jcin.2018.08.034. |
| 34506898 | Derived | Lyden SP, Brodmann M, Parikh SA, Krishnan P, Schroeder H, Werner M, Holden A, Ouriel K, Tarra T, Gray WA. Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials. J Vasc Surg. 2022 Feb;75(2):600-607. doi: 10.1016/j.jvs.2021.07.244. Epub 2021 Sep 8. |
| 31567024 | Derived | Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP. Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years. Circulation. 2019 Oct;140(14):1145-1155. doi: 10.1161/CIRCULATIONAHA.119.040518. Epub 2019 Sep 30. |
| Lost to Follow-up |
|
Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. Bare Percutaneous Transluminal Angioplasty Balloon Catheter |
| BG002 | Total | Total of all reporting groups |
| lesions |
|
| years |
| Participants |
|
|
| Sex: Female, Male | Count of Participants | Participants | Participants |
|
|
| Rutherford Clinical Category | The Rutherford-Becker Clinical Categories (RCC) are a classification system of chronic limb ischemia ranging from 0 (asymptomatic; no hemodynamically significant occlusive disease) to 6 (major tissue loss, extending above transmetatarsal level, functional foot no longer salvageable). Lower categories represent better clinical status. | The Rutherford Clinical Category assessment was missing for 1 Paclitaxel-coated Balloon patient and for 1 Bare Balloon patient. | Count of Participants | Participants | Participants |
|
|
| Diabetes | Count of Participants | Participants | Participants |
|
|
| Hypertension | Count of Participants | Participants | Participants |
|
|
| Hyperlipidemia | Count of Participants | Participants | Participants |
|
|
| Smoking status | Count of Participants | Participants | Participants |
|
|
| Baseline Ankle Brachial Index | The Ankle-Brachial Index (ABI) is calculated ratio of the highest ankle blood pressure to the highest arm blood pressure. The ABI is a non-invasive tool for screening for Peripheral Artery Disease. | The ABI is part of the most missed assessments at baseline which accounts for the missing data. For some participants, ABI is non-measurable or the number too high suggesting non-compressible vessels (with a pressure cuff) and thus cannot be reported. | Mean | Standard Deviation | ratio | Participants |
|
|
| Lesion length (mm) | For 3 Paclitaxel-coated Balloon subjects, the Core Laboratory considered the treated area as 1 lesion instead of 2 lesions as reported by the sites. For 1 lesion, the Core Laboratory could only assess lesion location and calcification based on available images (All other baseline lesion characteristics are missing). | Mean | Standard Deviation | mm | lesions |
|
|
| Lesion type | Count of Units | lesions | lesions |
|
|
| Total Occlusion | For 3 Paclitaxel-coated Balloon subjects, the Core Laboratory considered the treated area as 1 lesion instead of 2 lesions as reported by the sites. For 1 lesion, the Core Laboratory could only assess lesion location and calcification based on available images (All other baseline lesion characteristics are missing). | Count of Units | lesions | lesions |
|
|
| Calcification | For 3 Paclitaxel-coated Balloon subjects, the Core Laboratory considered the treated area as 1 lesion instead of 2 lesions as reported by the sites. For 1 lesion, the Core Laboratory could only assess lesion location and calcification based on available images (All other baseline lesion characteristics are missing). | Count of Units | lesions | lesions |
|
|
| Diameter stenosis | Diameter stenosis is calculated as the difference between the minimal luminal diameter (MLD) from the target reference vessel diameter (RVD), divided by the RVD, and multiplied by 100 to get the percentage of stenosis. The RVD is typically calculated by averaging the MLD of the healthy part of the vessel both proximal and distal to the vessel lesion | For 3 Paclitaxel-coated Balloon subjects, the Core Laboratory considered the treated area as 1 lesion instead of 2 lesions as reported by the sites. For 1 lesion, the Core Laboratory could only assess lesion location and calcification based on available images (All other baseline lesion characteristics are missing). | Mean | Standard Deviation | % Diameter Stenosis | lesions |
|
|
| Reference vessel Diameter | For 3 DCB subjects, the Core Laboratory considered the treated area as 1 lesion instead of 2 lesions as reported by the sites. For 1 lesion, the Core Laboratory could only assess lesion location and calcification based on avalaible images (All other baseline lesion characterics are missing). | Mean | Standard Deviation | mm | lesions |
|
|
| # of patent run-off vessels | The lesions characterics are reported as analyzed by angiographic core laboratory by quantitative angiography. | Count of Participants | Participants | Participants |
|
|
| pre-dilatation performed | Count of Units | lesions | lesions |
|
|
| Body Mass Index (BMI) | Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women. | BMI data was not available for 4 participants in the Paclitaxel-coated balloon group. | Mean | Standard Deviation | kg/m^2 | Participants |
|
|
| OG001 | Bare Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. Bare Percutaneous Transluminal Angioplasty Balloon Catheter |
|
|
| Primary | Percentage of Patients With Freedom From Device and Procedure Related Target Limb Major Amputation or Death Through 30-days Post-procedure and Clinically-driven Target Lesion Revascularization at 12-month | The primary safety endpoint was freedom from device and procedure-related death through 30 days post-procedure and freedom from target limb major amputation and clinically-driven target lesion revascularization (CD-TLR) through 12 months post-procedure. | Posted | Number | 95% Confidence Interval | percentage of participants | 30-Days and 12-Months |
|
|
|
| 35 |
| 219 |
| 118 |
| 219 |
| 180 |
| 219 |
| EG001 | Bare Balloon | Subjects with de novo occluded/stenotic or re-occluded/restenotic lesions will be randomly assigned to treatment with a Paclitaxel-coated balloon or bare balloon. Bare Percutaneous Transluminal Angioplasty Balloon Catheter | 9 | 68 | 38 | 68 | 51 | 68 |
| IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | Systematic Assessment |
|
| ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Systematic Assessment |
|
| ANGINA PECTORIS | Cardiac disorders | Systematic Assessment |
|
| ANGINA UNSTABLE | Cardiac disorders | Systematic Assessment |
|
| ARTERIOSCLEROSIS CORONARY ARTERY | Cardiac disorders | Systematic Assessment |
|
| ATRIAL FIBRILLATION | Cardiac disorders | Systematic Assessment |
|
| ATRIAL FLUTTER | Cardiac disorders | Systematic Assessment |
|
| BRADYCARDIA | Cardiac disorders | Systematic Assessment |
|
| CARDIAC ARREST | Cardiac disorders | Systematic Assessment |
|
| CARDIAC FAILURE | Cardiac disorders | Systematic Assessment |
|
| CORONARY ARTERY DISEASE | Cardiac disorders | Systematic Assessment |
|
| CORONARY ARTERY STENOSIS | Cardiac disorders | Systematic Assessment |
|
| MYOCARDIAL INFARCTION | Cardiac disorders | Systematic Assessment |
|
| SUPRAVENTRICULAR TACHYCARDIA | Cardiac disorders | Systematic Assessment |
|
| ENDOCARDIAL FIBROELASTOSIS | Congenital, familial and genetic disorders | Systematic Assessment |
|
| CATARACT | Eye disorders | Systematic Assessment |
|
| EYELID PTOSIS | Eye disorders | Systematic Assessment |
|
| LENS DISLOCATION | Eye disorders | Systematic Assessment |
|
| MACULAR DEGENERATION | Eye disorders | Systematic Assessment |
|
| RETINAL ARTERY OCCLUSION | Eye disorders | Systematic Assessment |
|
| RETINAL DETACHMENT | Eye disorders | Systematic Assessment |
|
| ABDOMINAL PAIN | Gastrointestinal disorders | Systematic Assessment |
|
| COLITIS | Gastrointestinal disorders | Systematic Assessment |
|
| COLITIS ULCERATIVE | Gastrointestinal disorders | Systematic Assessment |
|
| CONSTIPATION | Gastrointestinal disorders | Systematic Assessment |
|
| CROHN'S DISEASE | Gastrointestinal disorders | Systematic Assessment |
|
| DYSPEPSIA | Gastrointestinal disorders | Systematic Assessment |
|
| GASTROINTESTINAL HAEMORRHAGE | Gastrointestinal disorders | Systematic Assessment |
|
| HAEMATOCHEZIA | Gastrointestinal disorders | Systematic Assessment |
|
| HAEMORRHOIDS | Gastrointestinal disorders | Systematic Assessment |
|
| INGUINAL HERNIA | Gastrointestinal disorders | Systematic Assessment |
|
| INTESTINAL ISCHAEMIA | Gastrointestinal disorders | Systematic Assessment |
|
| LARGE INTESTINAL ULCER | Gastrointestinal disorders | Systematic Assessment |
|
| LARGE INTESTINE POLYP | Gastrointestinal disorders | Systematic Assessment |
|
| NAUSEA | Gastrointestinal disorders | Systematic Assessment |
|
| PANCREATITIS | Gastrointestinal disorders | Systematic Assessment |
|
| PANCREATITIS CHRONIC | Gastrointestinal disorders | Systematic Assessment |
|
| PROCTITIS | Gastrointestinal disorders | Systematic Assessment |
|
| UPPER GASTROINTESTINAL HAEMORRHAGE | Gastrointestinal disorders | Systematic Assessment |
|
| CATHETER SITE HAEMATOMA | General disorders | Systematic Assessment |
|
| CATHETER SITE HAEMORRHAGE | General disorders | Systematic Assessment |
|
| CHEST PAIN | General disorders | Systematic Assessment |
|
| DEVICE OCCLUSION | General disorders | Systematic Assessment |
|
| GENERAL PHYSICAL HEALTH DETERIORATION | General disorders | Systematic Assessment |
|
| IMPAIRED HEALING | General disorders | Systematic Assessment |
|
| NECROSIS | General disorders | Systematic Assessment |
|
| PAIN | General disorders | Systematic Assessment |
|
| THROMBOSIS IN DEVICE | General disorders | Systematic Assessment |
|
| CHOLECYSTITIS ACUTE | Hepatobiliary disorders | Systematic Assessment |
|
| CHOLESTASIS | Hepatobiliary disorders | Systematic Assessment |
|
| HEPATIC CIRRHOSIS | Hepatobiliary disorders | Systematic Assessment |
|
| HEPATIC FAILURE | Hepatobiliary disorders | Systematic Assessment |
|
| ESCHERICHIA INFECTION | Infections and infestations | Systematic Assessment |
|
| GASTROENTERITIS VIRAL | Infections and infestations | Systematic Assessment |
|
| GASTROINTESTINAL INFECTION | Infections and infestations | Systematic Assessment |
|
| PERITONITIS | Infections and infestations | Systematic Assessment |
|
| PNEUMONIA | Infections and infestations | Systematic Assessment |
|
| PNEUMONIA KLEBSIELLA | Infections and infestations | Systematic Assessment |
|
| RESPIRATORY TRACT INFECTION | Infections and infestations | Systematic Assessment |
|
| TUBERCULOSIS | Infections and infestations | Systematic Assessment |
|
| TUBERCULOSIS OF GENITOURINARY SYSTEM | Infections and infestations | Systematic Assessment |
|
| URINARY TRACT INFECTION | Infections and infestations | Systematic Assessment |
|
| CONFUSION POSTOPERATIVE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| FEMORAL NECK FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| FEMUR FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| HUMERUS FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| INCISIONAL HERNIA | Injury, poisoning and procedural complications | Systematic Assessment |
|
| LACERATION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| LUMBAR VERTEBRAL FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| MULTIPLE FRACTURES | Injury, poisoning and procedural complications | Systematic Assessment |
|
| PERIPHERAL ARTERIAL REOCCLUSION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| PERIPHERAL ARTERY RESTENOSIS | Injury, poisoning and procedural complications | Systematic Assessment |
|
| RADIUS FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| TENDON INJURY | Injury, poisoning and procedural complications | Systematic Assessment |
|
| VASCULAR PSEUDOANEURYSM | Injury, poisoning and procedural complications | Systematic Assessment |
|
| BLOOD GLUCOSE FLUCTUATION | Investigations | Systematic Assessment |
|
| DEHYDRATION | Metabolism and nutrition disorders | Systematic Assessment |
|
| HYPERGLYCAEMIA | Metabolism and nutrition disorders | Systematic Assessment |
|
| HYPOGLYCAEMIA | Metabolism and nutrition disorders | Systematic Assessment |
|
| TYPE 2 DIABETES MELLITUS | Metabolism and nutrition disorders | Systematic Assessment |
|
| BACK PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| FACET JOINT SYNDROME | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| INTERVERTEBRAL DISC PROTRUSION | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| JOINT SWELLING | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| MUSCULOSKELETAL PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| OSTEOARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| PAIN IN EXTREMITY | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| ROTATOR CUFF SYNDROME | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SPINAL OSTEOARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SPONDYLOLISTHESIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| ADENOCARCINOMA OF COLON | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BENIGN NEOPLASM | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BRAIN NEOPLASM | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BREAST CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BRONCHIAL CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| COLON CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| GASTRIC CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| GASTROINTESTINAL TRACT ADENOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| METASTASIS | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| PANCREATIC CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| POLYCYTHAEMIA VERA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| PROSTATE CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| SQUAMOUS CELL CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| SQUAMOUS CELL CARCINOMA OF SKIN | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| ATAXIA | Nervous system disorders | Systematic Assessment |
|
| CAROTID ARTERY STENOSIS | Nervous system disorders | Systematic Assessment |
|
| CEREBRAL HAEMORRHAGE | Nervous system disorders | Systematic Assessment |
|
| CEREBROVASCULAR ACCIDENT | Nervous system disorders | Systematic Assessment |
|
| ISCHAEMIC CEREBRAL INFARCTION | Nervous system disorders | Systematic Assessment |
|
| MIGRAINE WITH AURA | Nervous system disorders | Systematic Assessment |
|
| DEPRESSION | Psychiatric disorders | Systematic Assessment |
|
| BLADDER MASS | Renal and urinary disorders | Systematic Assessment |
|
| RENAL ARTERY STENOSIS | Renal and urinary disorders | Systematic Assessment |
|
| RENAL FAILURE | Renal and urinary disorders | Systematic Assessment |
|
| URINARY RETENTION | Renal and urinary disorders | Systematic Assessment |
|
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| EPISTAXIS | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PLEURAL EFFUSION | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PNEUMOTHORAX | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PULMONARY EMBOLISM | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| RESPIRATORY FAILURE | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| SLEEP APNOEA SYNDROME | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| SKIN ULCER | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| CAROTID ENDARTERECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| CARPAL TUNNEL DECOMPRESSION | Surgical and medical procedures | Systematic Assessment |
|
| CHOLECYSTECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| CORONARY ARTERY BYPASS | Surgical and medical procedures | Systematic Assessment |
|
| GASTROINTESTINAL DILATION PROCEDURE | Surgical and medical procedures | Systematic Assessment |
|
| KNEE ARTHROPLASTY | Surgical and medical procedures | Systematic Assessment |
|
| PERIPHERAL ENDARTERECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| BLUE TOE SYNDROME | Vascular disorders | Systematic Assessment |
|
| CIRCULATORY COLLAPSE | Vascular disorders | Systematic Assessment |
|
| DEEP VEIN THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| FEMORAL ARTERY DISSECTION | Vascular disorders | Systematic Assessment |
|
| FEMORAL ARTERY OCCLUSION | Vascular disorders | Systematic Assessment |
|
| HYPERTENSIVE CRISIS | Vascular disorders | Systematic Assessment |
|
| INTERMITTENT CLAUDICATION | Vascular disorders | Systematic Assessment |
|
| PELVIC VENOUS THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY DISSECTION | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY STENOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL EMBOLISM | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ISCHAEMIA | Vascular disorders | Systematic Assessment |
|
| THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| VENOUS THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| EOSINOPHILIA | Blood and lymphatic system disorders | Systematic Assessment |
|
| IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | Systematic Assessment |
|
| ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Systematic Assessment |
|
| ANGINA PECTORIS | Cardiac disorders | Systematic Assessment |
|
| ANGINA UNSTABLE | Cardiac disorders | Systematic Assessment |
|
| ARRHYTHMIA | Cardiac disorders | Systematic Assessment |
|
| ARTERIOSCLEROSIS CORONARY ARTERY | Cardiac disorders | Systematic Assessment |
|
| ATRIAL FIBRILLATION | Cardiac disorders | Systematic Assessment |
|
| ATRIAL FLUTTER | Cardiac disorders | Systematic Assessment |
|
| BRADYCARDIA | Cardiac disorders | Systematic Assessment |
|
| CARDIAC ARREST | Cardiac disorders | Systematic Assessment |
|
| CARDIAC FAILURE | Cardiac disorders | Systematic Assessment |
|
| CORONARY ARTERY DISEASE | Cardiac disorders | Systematic Assessment |
|
| CORONARY ARTERY STENOSIS | Cardiac disorders | Systematic Assessment |
|
| MYOCARDIAL INFARCTION | Cardiac disorders | Systematic Assessment |
|
| SUPRAVENTRICULAR TACHYCARDIA | Cardiac disorders | Systematic Assessment |
|
| TACHYCARDIA | Cardiac disorders | Systematic Assessment |
|
| ENDOCARDIAL FIBROELASTOSIS | Congenital, familial and genetic disorders | Systematic Assessment |
|
| CERUMEN IMPACTION | Ear and labyrinth disorders | Systematic Assessment |
|
| VERTIGO | Ear and labyrinth disorders | Systematic Assessment |
|
| HYPERTHYROIDISM | Endocrine disorders | Systematic Assessment |
|
| CATARACT | Eye disorders | Systematic Assessment |
|
| CHORIORETINOPATHY | Eye disorders | Systematic Assessment |
|
| DIABETIC RETINOPATHY | Eye disorders | Systematic Assessment |
|
| EYELID PTOSIS | Eye disorders | Systematic Assessment |
|
| LENS DISLOCATION | Eye disorders | Systematic Assessment |
|
| MACULAR DEGENERATION | Eye disorders | Systematic Assessment |
|
| RETINAL ARTERY OCCLUSION | Eye disorders | Systematic Assessment |
|
| RETINAL DETACHMENT | Eye disorders | Systematic Assessment |
|
| VITREOUS HAEMORRHAGE | Eye disorders | Systematic Assessment |
|
| ABDOMINAL PAIN | Gastrointestinal disorders | Systematic Assessment |
|
| ABDOMINAL PAIN LOWER | Gastrointestinal disorders | Systematic Assessment |
|
| ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Systematic Assessment |
|
| COLITIS | Gastrointestinal disorders | Systematic Assessment |
|
| COLITIS ULCERATIVE | Gastrointestinal disorders | Systematic Assessment |
|
| CONSTIPATION | Gastrointestinal disorders | Systematic Assessment |
|
| CROHN'S DISEASE | Gastrointestinal disorders | Systematic Assessment |
|
| DYSPEPSIA | Gastrointestinal disorders | Systematic Assessment |
|
| GASTRITIS | Gastrointestinal disorders | Systematic Assessment |
|
| GASTROINTESTINAL HAEMORRHAGE | Gastrointestinal disorders | Systematic Assessment |
|
| HAEMATOCHEZIA | Gastrointestinal disorders | Systematic Assessment |
|
| HAEMORRHOIDS | Gastrointestinal disorders | Systematic Assessment |
|
| INGUINAL HERNIA | Gastrointestinal disorders | Systematic Assessment |
|
| INTESTINAL ISCHAEMIA | Gastrointestinal disorders | Systematic Assessment |
|
| INTESTINAL POLYP | Gastrointestinal disorders | Systematic Assessment |
|
| LARGE INTESTINAL ULCER | Gastrointestinal disorders | Systematic Assessment |
|
| LARGE INTESTINE POLYP | Gastrointestinal disorders | Systematic Assessment |
|
| NAUSEA | Gastrointestinal disorders | Systematic Assessment |
|
| OESOPHAGITIS | Gastrointestinal disorders | Systematic Assessment |
|
| PANCREATITIS | Gastrointestinal disorders | Systematic Assessment |
|
| PANCREATITIS CHRONIC | Gastrointestinal disorders | Systematic Assessment |
|
| PROCTITIS | Gastrointestinal disorders | Systematic Assessment |
|
| SALIVARY GLAND CYST | Gastrointestinal disorders | Systematic Assessment |
|
| TOOTH DISORDER | Gastrointestinal disorders | Systematic Assessment |
|
| UPPER GASTROINTESTINAL HAEMORRHAGE | Gastrointestinal disorders | Systematic Assessment |
|
| CATHETER SITE HAEMATOMA | General disorders | Systematic Assessment |
|
| CATHETER SITE HAEMORRHAGE | General disorders | Systematic Assessment |
|
| CHEST DISCOMFORT | General disorders | Systematic Assessment |
|
| CHEST PAIN | General disorders | Systematic Assessment |
|
| DEVICE BREAKAGE | General disorders | Systematic Assessment |
|
| DEVICE OCCLUSION | General disorders | Systematic Assessment |
|
| FATIGUE | General disorders | Systematic Assessment |
|
| GENERAL PHYSICAL HEALTH DETERIORATION | General disorders | Systematic Assessment |
|
| IMPAIRED HEALING | General disorders | Systematic Assessment |
|
| LOCAL SWELLING | General disorders | Systematic Assessment |
|
| LOCALISED OEDEMA | General disorders | Systematic Assessment |
|
| NECROSIS | General disorders | Systematic Assessment |
|
| OEDEMA | General disorders | Systematic Assessment |
|
| OEDEMA PERIPHERAL | General disorders | Systematic Assessment |
|
| PAIN | General disorders | Systematic Assessment |
|
| PUNCTURE SITE HAEMORRHAGE | General disorders | Systematic Assessment |
|
| THROMBOSIS IN DEVICE | General disorders | Systematic Assessment |
|
| BILIARY CIRRHOSIS PRIMARY | Hepatobiliary disorders | Systematic Assessment |
|
| CHOLECYSTITIS ACUTE | Hepatobiliary disorders | Systematic Assessment |
|
| CHOLELITHIASIS | Hepatobiliary disorders | Systematic Assessment |
|
| CHOLESTASIS | Hepatobiliary disorders | Systematic Assessment |
|
| HEPATIC CIRRHOSIS | Hepatobiliary disorders | Systematic Assessment |
|
| HEPATIC FAILURE | Hepatobiliary disorders | Systematic Assessment |
|
| LIVER DISORDER | Hepatobiliary disorders | Systematic Assessment |
|
| HYPERSENSITIVITY | Immune system disorders | Systematic Assessment |
|
| BRONCHITIS | Infections and infestations | Systematic Assessment |
|
| EAR INFECTION | Infections and infestations | Systematic Assessment |
|
| ERYSIPELAS | Infections and infestations | Systematic Assessment |
|
| ESCHERICHIA INFECTION | Infections and infestations | Systematic Assessment |
|
| FUNGAL INFECTION | Infections and infestations | Systematic Assessment |
|
| GASTROENTERITIS | Infections and infestations | Systematic Assessment |
|
| GASTROENTERITIS VIRAL | Infections and infestations | Systematic Assessment |
|
| GASTROINTESTINAL INFECTION | Infections and infestations | Systematic Assessment |
|
| HERPES ZOSTER | Infections and infestations | Systematic Assessment |
|
| INFLUENZA | Infections and infestations | Systematic Assessment |
|
| NASOPHARYNGITIS | Infections and infestations | Systematic Assessment |
|
| OSTEOMYELITIS | Infections and infestations | Systematic Assessment |
|
| PERITONITIS | Infections and infestations | Systematic Assessment |
|
| PNEUMONIA | Infections and infestations | Systematic Assessment |
|
| PNEUMONIA KLEBSIELLA | Infections and infestations | Systematic Assessment |
|
| RESPIRATORY TRACT INFECTION | Infections and infestations | Systematic Assessment |
|
| SINUSITIS | Infections and infestations | Systematic Assessment |
|
| TONSILLITIS | Infections and infestations | Systematic Assessment |
|
| TUBERCULOSIS | Infections and infestations | Systematic Assessment |
|
| TUBERCULOSIS OF GENITOURINARY SYSTEM | Infections and infestations | Systematic Assessment |
|
| UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Systematic Assessment |
|
| URINARY TRACT INFECTION | Infections and infestations | Systematic Assessment |
|
| ACCIDENTAL OVERDOSE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| ANIMAL BITE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| ARTERIAL RESTENOSIS | Injury, poisoning and procedural complications | Systematic Assessment |
|
| BRAIN CONTUSION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| CONCUSSION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| CONFUSION POSTOPERATIVE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| CONTUSION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| FALL | Injury, poisoning and procedural complications | Systematic Assessment |
|
| FEMORAL NECK FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| FEMUR FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| HAND FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| HUMERUS FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| INCISIONAL HERNIA | Injury, poisoning and procedural complications | Systematic Assessment |
|
| INJURY | Injury, poisoning and procedural complications | Systematic Assessment |
|
| JOINT DISLOCATION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| LACERATION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| LUMBAR VERTEBRAL FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| MULTIPLE FRACTURES | Injury, poisoning and procedural complications | Systematic Assessment |
|
| NECK INJURY | Injury, poisoning and procedural complications | Systematic Assessment |
|
| PERIPHERAL ARTERIAL REOCCLUSION | Injury, poisoning and procedural complications | Systematic Assessment |
|
| PERIPHERAL ARTERY RESTENOSIS | Injury, poisoning and procedural complications | Systematic Assessment |
|
| POST PROCEDURAL HAEMATOMA | Injury, poisoning and procedural complications | Systematic Assessment |
|
| RADIUS FRACTURE | Injury, poisoning and procedural complications | Systematic Assessment |
|
| SEROMA | Injury, poisoning and procedural complications | Systematic Assessment |
|
| SPINAL COLUMN INJURY | Injury, poisoning and procedural complications | Systematic Assessment |
|
| TENDON INJURY | Injury, poisoning and procedural complications | Systematic Assessment |
|
| TRAUMATIC ULCER | Injury, poisoning and procedural complications | Systematic Assessment |
|
| VASCULAR PSEUDOANEURYSM | Injury, poisoning and procedural complications | Systematic Assessment |
|
| WOUND | Injury, poisoning and procedural complications | Systematic Assessment |
|
| ANKLE BRACHIAL INDEX DECREASED | Investigations | Systematic Assessment |
|
| BLOOD CHOLESTEROL INCREASED | Investigations | Systematic Assessment |
|
| BLOOD COUNT ABNORMAL | Investigations | Systematic Assessment |
|
| BLOOD GLUCOSE FLUCTUATION | Investigations | Systematic Assessment |
|
| BLOOD PRESSURE INCREASED | Investigations | Systematic Assessment |
|
| INTRAOCULAR PRESSURE INCREASED | Investigations | Systematic Assessment |
|
| WEIGHT DECREASED | Investigations | Systematic Assessment |
|
| DEHYDRATION | Metabolism and nutrition disorders | Systematic Assessment |
|
| GOUT | Metabolism and nutrition disorders | Systematic Assessment |
|
| HYPERGLYCAEMIA | Metabolism and nutrition disorders | Systematic Assessment |
|
| HYPOGLYCAEMIA | Metabolism and nutrition disorders | Systematic Assessment |
|
| TYPE 2 DIABETES MELLITUS | Metabolism and nutrition disorders | Systematic Assessment |
|
| ARTHRALGIA | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| ARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| BACK PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| BONE PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| BURSITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| EXOSTOSIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| FACET JOINT SYNDROME | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| GROIN PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| INTERVERTEBRAL DISC DEGENERATION | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| INTERVERTEBRAL DISC PROTRUSION | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| JOINT EFFUSION | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| JOINT SWELLING | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| MUSCLE SPASMS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| MUSCULAR WEAKNESS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| MUSCULOSKELETAL PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| MYALGIA | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| NECK PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| OSTEOARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| OSTEOCHONDRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| OSTEOCHONDROSIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| PAIN IN EXTREMITY | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| RHEUMATOID ARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| ROTATOR CUFF SYNDROME | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SINUS TARSI SYNDROME | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SPINAL OSTEOARTHRITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SPINAL PAIN | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| SPONDYLOLISTHESIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| TENDONITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| TENOSYNOVITIS | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| TRIGGER FINGER | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| ADENOCARCINOMA OF COLON | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| ADRENAL ADENOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BENIGN NEOPLASM | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BRAIN NEOPLASM | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BREAST CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| BRONCHIAL CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| COLON CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| GASTRIC CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| GASTROINTESTINAL TRACT ADENOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| LIPOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| METASTASIS | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| PANCREATIC CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| POLYCYTHAEMIA VERA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| PROSTATE CANCER | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| SQUAMOUS CELL CARCINOMA | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| SQUAMOUS CELL CARCINOMA OF SKIN | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment |
|
| ATAXIA | Nervous system disorders | Systematic Assessment |
|
| CAROTID ARTERY OCCLUSION | Nervous system disorders | Systematic Assessment |
|
| CAROTID ARTERY STENOSIS | Nervous system disorders | Systematic Assessment |
|
| CARPAL TUNNEL SYNDROME | Nervous system disorders | Systematic Assessment |
|
| CEREBRAL HAEMORRHAGE | Nervous system disorders | Systematic Assessment |
|
| CEREBROVASCULAR ACCIDENT | Nervous system disorders | Systematic Assessment |
|
| CERVICOBRACHIAL SYNDROME | Nervous system disorders | Systematic Assessment |
|
| DIZZINESS | Nervous system disorders | Systematic Assessment |
|
| HEADACHE | Nervous system disorders | Systematic Assessment |
|
| HYPOAESTHESIA | Nervous system disorders | Systematic Assessment |
|
| ISCHAEMIC CEREBRAL INFARCTION | Nervous system disorders | Systematic Assessment |
|
| MIGRAINE WITH AURA | Nervous system disorders | Systematic Assessment |
|
| PARAESTHESIA | Nervous system disorders | Systematic Assessment |
|
| POLYNEUROPATHY | Nervous system disorders | Systematic Assessment |
|
| RESTLESS LEGS SYNDROME | Nervous system disorders | Systematic Assessment |
|
| SENSORY LOSS | Nervous system disorders | Systematic Assessment |
|
| TRIGEMINAL NEURALGIA | Nervous system disorders | Systematic Assessment |
|
| DELIRIUM | Psychiatric disorders | Systematic Assessment |
|
| DEPRESSION | Psychiatric disorders | Systematic Assessment |
|
| BLADDER MASS | Renal and urinary disorders | Systematic Assessment |
|
| POLLAKIURIA | Renal and urinary disorders | Systematic Assessment |
|
| RENAL ARTERY STENOSIS | Renal and urinary disorders | Systematic Assessment |
|
| RENAL FAILURE | Renal and urinary disorders | Systematic Assessment |
|
| URGE INCONTINENCE | Renal and urinary disorders | Systematic Assessment |
|
| URINARY RETENTION | Renal and urinary disorders | Systematic Assessment |
|
| BRONCHITIS CHRONIC | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| DYSPNOEA | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| EPISTAXIS | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PLEURAL EFFUSION | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PNEUMOTHORAX | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| PULMONARY EMBOLISM | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| RESPIRATORY FAILURE | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| SLEEP APNOEA SYNDROME | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| BLISTER | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| DRUG ERUPTION | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| ECZEMA | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| PRURITUS | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| RASH | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| SKIN LESION | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| SKIN ULCER | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| SUBCUTANEOUS EMPHYSEMA | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| CAROTID ENDARTERECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| CARPAL TUNNEL DECOMPRESSION | Surgical and medical procedures | Systematic Assessment |
|
| CHOLECYSTECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| CORONARY ARTERY BYPASS | Surgical and medical procedures | Systematic Assessment |
|
| GASTROINTESTINAL DILATION PROCEDURE | Surgical and medical procedures | Systematic Assessment |
|
| KNEE ARTHROPLASTY | Surgical and medical procedures | Systematic Assessment |
|
| MOLE EXCISION | Surgical and medical procedures | Systematic Assessment |
|
| PERIPHERAL ENDARTERECTOMY | Surgical and medical procedures | Systematic Assessment |
|
| ANGIODYSPLASIA | Vascular disorders | Systematic Assessment |
|
| BLUE TOE SYNDROME | Vascular disorders | Systematic Assessment |
|
| CIRCULATORY COLLAPSE | Vascular disorders | Systematic Assessment |
|
| DEEP VEIN THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| FEMORAL ARTERY DISSECTION | Vascular disorders | Systematic Assessment |
|
| FEMORAL ARTERY OCCLUSION | Vascular disorders | Systematic Assessment |
|
| HAEMATOMA | Vascular disorders | Systematic Assessment |
|
| HYPERTENSION | Vascular disorders | Systematic Assessment |
|
| HYPERTENSIVE CRISIS | Vascular disorders | Systematic Assessment |
|
| INTERMITTENT CLAUDICATION | Vascular disorders | Systematic Assessment |
|
| LYMPHOEDEMA | Vascular disorders | Systematic Assessment |
|
| PELVIC VENOUS THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY DISSECTION | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY STENOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ARTERY THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL EMBOLISM | Vascular disorders | Systematic Assessment |
|
| PERIPHERAL ISCHAEMIA | Vascular disorders | Systematic Assessment |
|
| THROMBOSIS | Vascular disorders | Systematic Assessment |
|
| VENOUS THROMBOSIS | Vascular disorders | Systematic Assessment |
|
Not provided
Not provided
| D002318 |
| Cardiovascular Diseases |
| D016491 | Peripheral Vascular Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
|
| Rutherford Clinical Category 4 |
|
| Title | Measurements |
|---|---|
|
| Title | Measurements |
|---|---|
|
| Title | Measurements |
|---|---|
|
| Severe |
|
| Title | Measurements |
|---|---|
|
| 2 |
|
| 3 |
|